Newbridge Financial Services Group, Inc. Laboratory Corp Of America Holdings Transaction History

Newbridge Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$209.01 - $232.56 $2,299 - $2,558	-11 Reduced 21.57%	40 $8,000
Q2 2023 Jul 21, 2023	SELL	$211.93 - $241.33 $4,238 - $4,826	-20 Reduced 28.17%	51 $12,000
Q4 2022 Jan 17, 2023	SELL	$203.72 - $248.97 $19,353 - $23,652	-95 Reduced 57.23%	71 $0
Q2 2022 Jul 15, 2022	SELL	$213.86 - $277.87 $1,924 - $2,500	-9 Reduced 5.14%	166 $39,000
Q1 2022 Apr 26, 2022	BUY	$259.82 - $298.18 $3,897 - $4,472	15 Added 9.38%	175 $46,000
Q4 2021 Jan 19, 2022	BUY	$271.6 - $314.21 $32,592 - $37,705	120 Added 300.0%	160 $50,000
Q2 2021 Sep 07, 2021	BUY	$251.87 - $278.14 $10,074 - $11,125	40 New	40 $11,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.